Pathstone Family Office, LLC Athira Pharma, Inc. Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 425,492 shares of ATHA stock, worth $187,216. This represents 0.01% of its overall portfolio holdings.
Number of Shares
425,492
Previous 425,492
-0.0%
Holding current value
$187,216
Previous $1.26 Million
31.55%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding ATHA
# of Institutions
74Shares Held
22.8MCall Options Held
73.4KPut Options Held
97.8K-
Perceptive Advisors LLC New York, NY5.4MShares$2.38 Million0.41% of portfolio
-
Baker Bros. Advisors LP New York, NY3.15MShares$1.39 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$719,1500.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$656,8282.57% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$656,8280.29% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $16.6M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...